• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“从这里无法到达那里”:当前对年轻活体肾脏捐献者的 ESRD 风险评估的关键障碍。

"You can't get there from here": Critical obstacles to current estimates of the ESRD risks of young living kidney donors.

机构信息

UCSD Center for Transplantation and Division of Nephrology, University of California at San Diego School of Medicine, San Diego, CA, USA.

出版信息

Am J Transplant. 2019 Jan;19(1):32-36. doi: 10.1111/ajt.15089. Epub 2018 Oct 3.

DOI:10.1111/ajt.15089
PMID:30137698
Abstract

Short studies that generate lifetime end-stage renal disease (ESRD) risks for young living kidney donors have conflicted with the knowledge and practice of nontransplant specialists. A widely accepted online risk calculator (OLRC) is no exception. It uses 6.4 year observations and an ostensibly empiric methodology to predict low lifetime risks for normal young candidates. But the nonspecific ESRD risk factors identified in this study are likely features of kidney diseases that were already underway at study entry. No practicing nephrologist would use their absence to predict any specific kidney disease that had yet to begin, which is essential for excluding high-risk individuals. The OLRC's risk estimates are particularly low because it also does not assign to young adults about 70% of the lifetime ESRD that they will experience as they age, which is part of their risk. It reinforces traditional concepts of low donor risk, minimizing the potential relevance of recent, sometimes concerning, long-term outcome data. These data suggest many similarities between postdonation ESRD and ESRD in the general population, about which much is already known. Despite our best efforts, the heterogeneity and exponential accumulation of end-stage kidney diseases over time prevent long-term predictions of risk for young kidney donors.

摘要

短期研究表明,年轻活体肾脏捐献者会终身面临终末期肾病(ESRD)风险,这与非移植专家的知识和实践相冲突。广受欢迎的在线风险计算器(OLRC)也不例外。它使用 6.4 年的观察结果和表面上的经验方法来预测正常年轻供体的低终身风险。但在这项研究中确定的非特异性 ESRD 风险因素很可能是已经在进行中的肾脏疾病的特征。没有任何执业肾病学家会根据这些因素来预测任何尚未开始的特定肾脏疾病,这对于排除高风险个体至关重要。OLRC 的风险估计特别低,因为它也没有将年轻人一生中约 70%的 ESRD 风险分配给年轻人,而这是他们风险的一部分。它强化了低供体风险的传统观念,最大限度地减少了最近有时令人担忧的长期结果数据的潜在相关性。这些数据表明,捐赠后 ESRD 与普通人群中的 ESRD 之间存在许多相似之处,关于这些问题已经有了很多了解。尽管我们尽了最大努力,但随着时间的推移,终末期肾脏疾病的异质性和指数积累,使得对年轻肾脏捐献者的风险进行长期预测变得不可能。

相似文献

1
"You can't get there from here": Critical obstacles to current estimates of the ESRD risks of young living kidney donors.“从这里无法到达那里”:当前对年轻活体肾脏捐献者的 ESRD 风险评估的关键障碍。
Am J Transplant. 2019 Jan;19(1):32-36. doi: 10.1111/ajt.15089. Epub 2018 Oct 3.
2
Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.早期捐肾后肾功能与活体肾供者终末期肾病风险的关联。
JAMA Surg. 2020 Mar 1;155(3):e195472. doi: 10.1001/jamasurg.2019.5472. Epub 2020 Mar 18.
3
Impact of the individualized risks of end-stage renal disease on living kidney donor selection.终末期肾病个体化风险对活体肾供者选择的影响。
Nephrol Dial Transplant. 2018 Dec 1;33(12):2245-2252. doi: 10.1093/ndt/gfy145.
4
Causes and timing of end-stage renal disease after living kidney donation.活体肾捐献后终末期肾病的病因和发生时间。
Am J Transplant. 2018 May;18(5):1140-1150. doi: 10.1111/ajt.14671. Epub 2018 Mar 1.
5
Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.活体肾供体中由糖尿病、高血压和肾小球肾炎引起的终末期肾病模式。
Am J Transplant. 2016 Dec;16(12):3540-3547. doi: 10.1111/ajt.13917. Epub 2016 Jul 12.
6
Obesity increases the risk of end-stage renal disease among living kidney donors.肥胖会增加活体肾供者发生终末期肾病的风险。
Kidney Int. 2017 Mar;91(3):699-703. doi: 10.1016/j.kint.2016.10.014. Epub 2016 Dec 29.
7
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.活体肾供体候选人的肾衰竭风险预测
N Engl J Med. 2016 Feb 4;374(5):411-21. doi: 10.1056/NEJMoa1510491. Epub 2015 Nov 6.
8
GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.在有(无)一级亲属患有 ESRD 的活体肾捐献者中,GFR 在捐肾后 25 年内≤。
Am J Transplant. 2018 Mar;18(3):625-631. doi: 10.1111/ajt.14525. Epub 2017 Dec 1.
9
Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.来自随后发展为终末期肾病的活体肾供体的同种异体移植物移植后的受者结局。
Am J Transplant. 2016 Dec;16(12):3532-3539. doi: 10.1111/ajt.13869. Epub 2016 Jun 27.
10
Risk of ESRD in prior living kidney donors.既往活体肾捐献者的终末期肾病风险。
Am J Transplant. 2018 May;18(5):1129-1139. doi: 10.1111/ajt.14678. Epub 2018 Mar 8.

引用本文的文献

1
Screening of Living Kidney Donors for Genetic Diseases: Commentary.活体肾供体的遗传病筛查:评论
Kidney360. 2024 Oct 1;5(10):1419-1421. doi: 10.34067/KID.0000000000000470. Epub 2024 May 15.
2
The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.明尼苏达州可归因于肾脏捐献的风险(MARKD)研究:一项回顾性队列研究,比较了长期(>50 年)肾脏捐献后与匹配良好的健康对照者的长期结果。
BMC Nephrol. 2023 May 1;24(1):121. doi: 10.1186/s12882-023-03149-7.
3
The Living Kidney Donor Safety Study: Protocol of a Prospective Cohort Study.
活体肾供体安全性研究:一项前瞻性队列研究的方案
Can J Kidney Health Dis. 2022 Oct 28;9:20543581221129442. doi: 10.1177/20543581221129442. eCollection 2022.
4
Long-term Medical Outcomes of Living Kidney Donors.活体肾移植供者的长期医疗结果。
Mayo Clin Proc. 2022 Nov;97(11):2107-2122. doi: 10.1016/j.mayocp.2022.06.013. Epub 2022 Oct 7.
5
Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool - a retrospective study.预测活体供肾移植中供者、受者和移植物的存活情况,为移植前咨询提供信息:供者和受者关联的 iPREDICTLIVING 工具——一项回顾性研究。
Transpl Int. 2020 Jul;33(7):729-739. doi: 10.1111/tri.13580. Epub 2020 Feb 24.